Interno di un nuraghe

 

Crescenzi, M, Napolitano, M, Carbonari, M, Antonelli, A, Petrinelli, P, Gaetano, C, and Fiorilli, M. Establishment of a new Epstein-Barr virus-immortalized cell line from chronic lymphocytic leukemia with trisomy of chromosome 12 that produces monoclonal IgM against a sheep RBC antigen. Blood 71:9-12, 1988.

Crescenzi, M, Seto, M, Herzig, GP, Weiss, PD, Griffith, RC, and Korsmeyer, SJ. Thermostable DNA Polymerase Chain Amplification of t(14;18) Chromosome Breakpoints and Detection of Minimal Residual Disease. Proc Natl Acad Sci USA 85:4869-4873, 1988.

Crescenzi, M. B-cell lymphoma: t(14;18) chromosome rearrangement. In: Innis, MA, DH Gelfand, JJ Sninsky and TJ White (eds). PCR protocols: a guide to methods and applications. Academic Press: New York (1990). pp 392-398.

Miki, T, Fleming, TP, Crescenzi, M, Molloy, CJ, Blam, SB, Reynolds, SH, and Aaronson, SA. Development of a highly efficient expression cDNA cloning system: Application to oncogene isolation. Proc Natl Acad Sci USA 88:5167-5171, 1991.

Marti, GE, Zenger, V, Brown, M, Marti, DM, Melo, JV, Crescenzi, M, Dadey, B, Han, T, Bertin, P, Caporaso, NE, and Noguchi, P. Antigenic expression of B-cell chronic lymphocytic leukemic cell lines. Leuk Lymphoma 7:497-504, 1992.

Crescenzi, M, Crouch, D, and Tato', F. Effects of myc expression on mouse myoblasts are reversed in mixed culture with normal cells. In: Rifkind, RA (ed). The pharmacology of cell differentiation. Elsevier Science Publishers: Amsterdam (1993). pp 157-166.

Crescenzi, M, Crouch, DH, and Tato', F. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells. J Cell Biol 125:1137-1145, 1994.

Falcioni, R, Antonini, A, Nistico', P, Di Stefano, S, Crescenzi, M, Natali, PG, and Sacchi, A. a6b4 and a6b1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res 236:76-85, 1997.

Moretti, F, Farsetti, A, Soddu, S, Misiti, S, Crescenzi, M, Filetti, S, and Andreoli, M. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene 14:729-740, 1997.

Scardigli, R, Bossi, G, Blandino, G, Crescenzi, M, Soddu, S, and Sacchi, A. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging. Gene Therapy 4:1371-1378, 1997.

Rizzo, MG, Zepparoni, A, Cristofanelli, B, Scardigli, R, Crescenzi, M, Blandino, G, Giuliacci, S, Ferrari, S, Soddu, S, and Sacchi, A. Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation. Brit J Cancer 77:1429-1438, 1998.

Giannini, G, Di Marcotullio, L, Ristori, E, Zani, M, Crescenzi, M, Scarpa, S, Piaggio, G, Vacca, A, Peverali, FA, Diana, F, Screpanti, I, Frati, L, and Gulino, A. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Cancer Res 59:2484-2492, 1999.

D'Orazi, G, Marchetti, A, Crescenzi, M, Coen, S, Sacchi, A, and Soddu, S. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting. J Gene Med 2:11-21, 2000.

Moretti, F, Nanni, S, Farsetti, A, Narducci, M, Crescenzi, M, Giuliacci, S, Sacchi, A, and Pontecorvi, A. Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status. J Clin Endocrinol Metab 85:302-308, 2000.

Colussi, C, Fiumicino, S, Giuliani, A, Rosini, S, Musiani, P, Macri, C, Potten, CS, Crescenzi, M, and Bignami, M. 1,2-Dimethylhydrazine-Induced Colon Carcinoma and Lymphoma in msh2(-/-) Mice. J Natl Cancer Inst 93:1534-1540, 2001.

Crescenzi, M, and Giuliani, A. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data. FEBS Letters 507:114-118, 2001.

Giannini, G, Ristori, E, Cerignoli, F, Rinaldi, C, Zani, M, Viel, A, Ottini, L, Crescenzi, M, Martinotti, S, Bignami, M, Frati, L, Screpanti, I, and Gulino, A. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 3:248-254, 2002.

Bossi, G, Mazzaro, G, Porrello, A, Crescenzi, M, Soddu, S, and Sacchi, A. Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy. Oncogene 23:418-425, 2004.

Nicassio, F, Bianchi, F, Capra, M, Vecchi, M, Confalonieri, S, Bianchi, M, Pajalunga, D, Crescenzi, M, Bonapace, IM, and Di Fiore, PP. A cancer-specific transcriptional signature in human neoplasia. J Clin Invest 115:3015-3025, 2005.

Casorelli, I, Tenedini, E, Tagliafico, E, Blasi, MF, Giuliani, A, Crescenzi, M, Pelosi, E, Testa, U, Peschle, C, Mele, L, Diverio, D, Breccia, M, Lo Coco, F, Ferrari, S, and Bignami, M. Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes. Leukemia 20:1978-1988, 2006.

Marzi, MJ, Puggioni, EM, Dall'olio, V, Bucci, G, Bernard, L, Bianchi, F, Crescenzi, M, Di Fiore, PP, and Nicassio, F. Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation. J Cell Biol 199:77-95, 2012.

Fosso, B, Santamaria, M, D'Antonio, M, Lovero, D, Corrado, G, Vizza, E, Passaro, N, Garbuglia, AR, Capobianchi, MR, Crescenzi, M, Valiente, G, and Pesole, G. MetaShot: an accurate workflow for taxon classification of host-associated microbiome from shotgun metagenomic data. Bioinformatics, 2017.

 

 

Per contattare Marco Crescenzi: Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.